Literature DB >> 34934794

A surprising complication of breast augmentation surgery.

Caroline Koan1, Rose J Venegas2, Richard A Murphy3,4.   

Abstract

Infections caused by opportunistic fungal organisms such as Scedosporium spp. have been increasingly recognized over the last few decades. Most affected patients are immunocompromised or critically ill, but Scedosporium spp. infections have also been described in immunocompetent patients, such as localized disease from direct inoculation or in near-drowning events. We describe a case of a patient with no known underlying immune impairment who experienced significant infection with Scedosporium apiospermum at both sites of breast augmentation. Once identified, the choice of therapeutics can be challenging given the intrinsic resistance and variable activity of different antifungal agents; however, other factors also impact the outcome of this infection such as the host immune status. Thus, both the recognition and treatment of Scedosporium infections can be challenging.
© 2021 The Author(s). Published by Elsevier Ltd on behalf of British Association of Plastic, Reconstructive and Aesthetic Surgeons.

Entities:  

Keywords:  Breast augmentation complication; Fungal infection; Implant infection; Plastic surgery

Year:  2021        PMID: 34934794      PMCID: PMC8661042          DOI: 10.1016/j.jpra.2021.10.010

Source DB:  PubMed          Journal:  JPRAS Open        ISSN: 2352-5878


  10 in total

Review 1.  Breast implant infections.

Authors:  Laraine L Washer; Karol Gutowski
Journal:  Infect Dis Clin North Am       Date:  2012-03       Impact factor: 5.982

2.  An outbreak of Mycobacterium jacuzzii infection following insertion of breast implants.

Authors:  G Rahav; S Pitlik; Z Amitai; A Lavy; M Blech; N Keller; G Smollan; M Lewis; A Zlotkin
Journal:  Clin Infect Dis       Date:  2006-08-28       Impact factor: 9.079

3.  Fontana-Masson stain in fungal infections.

Authors:  Kelly Leigh West; Alan D Proia; Puja Kumari Puri
Journal:  J Am Acad Dermatol       Date:  2017-04-06       Impact factor: 11.527

Review 4.  Scedosporium and Lomentospora: an updated overview of underrated opportunists.

Authors:  Andoni Ramirez-Garcia; Aize Pellon; Aitor Rementeria; Idoia Buldain; Eliana Barreto-Bergter; Rodrigo Rollin-Pinheiro; Jardel Vieira de Meirelles; Mariana Ingrid D S Xisto; Stephane Ranque; Vladimir Havlicek; Patrick Vandeputte; Yohann Le Govic; Jean-Philippe Bouchara; Sandrine Giraud; Sharon Chen; Johannes Rainer; Ana Alastruey-Izquierdo; Maria Teresa Martin-Gomez; Leyre M López-Soria; Javier Peman; Carsten Schwarz; Anne Bernhardt; Kathrin Tintelnot; Javier Capilla; Adela Martin-Vicente; Jose Cano-Lira; Markus Nagl; Michaela Lackner; Laszlo Irinyi; Wieland Meyer; Sybren de Hoog; Fernando L Hernando
Journal:  Med Mycol       Date:  2018-04-01       Impact factor: 4.076

5.  Breast implant infections: is cefazolin enough?

Authors:  Evan M Feldman; Dimitrios P Kontoyiannis; Safa E Sharabi; Edward Lee; Yoav Kaufman; Lior Heller
Journal:  Plast Reconstr Surg       Date:  2010-09       Impact factor: 4.730

6.  Unique histological characteristics of Scedosporium that could aid in its identification.

Authors:  Masatomo Kimura; Osamu Maenishi; Hiroyuki Ito; Kiyofumi Ohkusu
Journal:  Pathol Int       Date:  2010-02       Impact factor: 2.534

Review 7.  Scedosporium apiospermum (Pseudoallescheria boydii) infection in lung transplant recipients.

Authors:  Hina Sahi; Robin K Avery; Omar A Minai; Geraldine Hall; Atul C Mehta; Paola Raina; Marie Budev
Journal:  J Heart Lung Transplant       Date:  2007-03-02       Impact factor: 10.247

8.  Early Postoperative Outcomes in Breast Conservation Surgery Versus Simple Mastectomy with Implant Reconstruction: A NSQIP Analysis of 11,645 Patients.

Authors:  Bryan Pyfer; Abhishek Chatterjee; Lilian Chen; John Nigriny; Brian Czerniecki; Julia Tchou; Carla Fisher
Journal:  Ann Surg Oncol       Date:  2015-07-29       Impact factor: 5.344

9.  Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients.

Authors:  Peter Troke; Koldo Aguirrebengoa; Carmen Arteaga; David Ellis; Christopher H Heath; Irja Lutsar; Montserrat Rovira; Quoc Nguyen; Monica Slavin; Sharon C A Chen
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.